COLLINS MORTON 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed May 13, 2019
Insider Transaction Report
Form 4
COLLINS MORTON
Director
Transactions
- Exercise/Conversion
Common Stock
2019-05-11+8,170→ 168,130 total - Exercise/Conversion
Restricted Stock Unit
2019-05-11−8,170→ 0 total→ Common Stock (8,170 underlying)
Holdings
- 6,450(indirect: By Spouse)
Common Stock
- 64,750(indirect: By Trust)
Common Stock
- 4,500(indirect: By Trust)
Common Stock
- 50,000(indirect: By IRA)
Common Stock
- 6,650(indirect: By Spouse)
Common Stock
- 64,750(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019.